"The Pill may lower cancer risk"
Source: Globe and Mail
Published: 25 Jan 2022
Category: Pharmaceutical
Rating:
(3½ stars)
what they said (Hover the mouse cursor over underlined words for more info)
The longer a woman takes birth-control pills, the lower her risk of developing ovarian cancer, according to a new study. The research, published in today's edition of the medical journal The Lancet, shows that women who take oral contraceptives for a decade can slash their cancer risk by more than one-third. By comparison, taking the Pill for up to four years reduces the risk of ovarian cancer by about 22 per cent....
The original article can be found at: http://www.theglobeandmail.com/servlet/story/RTGAM.20080125.wlpill25/BNStory/specialScienceandHealth
The original article can found in the Media Doctor archives.
Criteria |
Rating |
Availability of Treatment |
Satisfactory (?) |
Novelty of Treatment |
Satisfactory (?) |
Disease Mongering |
Satisfactory (?) |
Treatment Options |
Not Satisfactory (?) |
Costs of Treatment |
Not Satisfactory (?) |
Evidence |
Satisfactory (?) |
Quantification of Benefits of Treatment |
Satisfactory (?) |
Harms of Treatment |
Satisfactory (?) |
Sources of Information |
Satisfactory (?) |
Relies on Press Release |
Not Applicable |
Quantification of Harms of Treatment |
Not Satisfactory (?) |
what we said (Hover the mouse cursor over underlined words for more info)
This story is about the potential for birth control pills to lower ovarian cancer risk. The evidence is well-explained, with the benefits presented in relative and absolute terms. It would have been useful to have had the harm data (the potential for adverse effects) also quantified as this information is needed for people to be able to compare benefits vs. harm. Total serious adverse event data is usually compiled in meta-analyses like this and would have been worthy of a mention in the media report. It is one thing to take the pill to reduce the risk of one cancer, it is another if the pill also causes other, perhaps equally serious diseases. As is common in stories like this the reader may be left with a false sense of optimism unless they read the full story which includes appropriate caveats (despite this study it remains 'unclear' whether women should take oral contraceptives specifically to reduce their risk of ovarian cancer).
public forum
There are currently no comments on this article.
|